1.
J Pediatr
; 149(3): 409-11, 2006 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16939758
RESUMO
This report describes the case of a 4-year-old boy diagnosed with Smith-Magenis syndrome in whom treatment with a beta(1)-adrenergic antagonist in the morning (to suppress the diurnal melatonin secretion) and melatonin in the evening (to generate a nocturnal peak of melatonin) improved his sleep quality, evaluated by polysomnographic studies.